Top

Clinical Rheumatology

Published in:

Open Access 01-09-2021 | Sarcoidosis | Original Paper

Whole genome sequencing identifies variants associated with sarcoidosis in a family with a high prevalence of sarcoidosis

Authors: Daan Fritz, Bart Ferwerda, Matthijs C. Brouwer, Diederik van de Beek

Published in: Clinical Rheumatology | Issue 9/2021

Abstract

Objective

We studied genetic risk factors associated with sarcoidosis within a family with a high prevalence of this disease.

Methods

We studied 41 members of a family with a high rate of sarcoidosis, including an index patient with treatment-resistant neurosarcoidosis. Whole genome sequencing was performed for six affected family members and variations associated with loss of function were filtered out as candidate genes. Findings were validated by using amplicon sequencing within all 41 family members with DNA available and candidate genes were screened on absence and presence within the sarcoidosis affected and non-affected.

Results

Family members (n = 61) from 5 generations were available for participation including 13 subjects diagnosed with sarcoidosis (20%). Analyses identified 36 candidate variants within 34 candidate genes. Variations within three of these genes (JAK2, BACH2, and NCF1) previously have been associated with autoimmune diseases.

Conclusions

We identified 34 genes with a possible role in the etiology of sarcoidosis, including JAK2. Our results may suggest evaluation of JAK inhibitors in treatment-resistant sarcoidosis.

Key Points

• JAK2 has a potential role in the etiology of sarcoidosis and is a potential therapeutic target.

• We identified 33 additional candidate genes of which BACH2 and NCF1 have been previously associated with autoimmune disease.

Available only for authorised users

Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Muller-Quernheim J (2014) Sarcoidosis. Lancet 383(9923):1155–1167. https://doi.org/10.1016/S0140-6736(13)60680-7CrossRefPubMed

Fritz D, van de Beek D, Brouwer MC (2016) Clinical features, treatment and outcome in neurosarcoidosis: Systematic review and meta-analysis. BMC Neurol 16(1):220. https://doi.org/10.1186/s12883-016-0741-xCrossRefPubMedPubMedCentral

Gabrilovich MI, Walrath J, van Lunteren J, Nethery D, Seifu M, Kern JA, Harding CV, Tuscano L, Lee H, Williams SD, Mackay W, Tomashefski JF Jr, Silver RF (2013) Disordered Toll-like receptor 2 responses in the pathogenesis of pulmonary sarcoidosis. Clin Exp Immunol 173(3):512–522. https://doi.org/10.1111/cei.12138CrossRefPubMedPubMedCentral

Fingerlin TE, Hamzeh N, Maier LA (2015) Genetics of sarcoidosis. Clin Chest Med 36(4):569–584. https://doi.org/10.1016/j.ccm.2015.08.002CrossRefPubMed

Sverrild A, Backer V, Kyvik KO, Kaprio J, Milman N, Svendsen CB, Thomsen SF (2008) Heredity in sarcoidosis: A registry-based twin study. Thorax 63(10):894–896. https://doi.org/10.1136/thx.2007.094060CrossRefPubMed

Cingolani P, Platts A, Wang Le L, Coon M, Nguyen T, Wang L, Land SJ, Lu X, Ruden DM (2012) A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 6(2):80–92. https://doi.org/10.4161/fly.19695CrossRef

Fisher RA (2015) Preface. RGS protein physiology and pathophysiology. Prog Mol Biol Transl Sci 133:xi–xii. https://doi.org/10.1016/S1877-1173(15)00122-2CrossRefPubMed

Sawano A, Iwai S, Sakurai Y, Ito M, Shitara K, Nakahata T, Shibuya M (2001) Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 97(3):785–791CrossRef

Zhou Y, Wu H, Zhao M, Chang C, Lu Q (2016) The Bach family of transcription factors: A comprehensive review. Clin Rev Allergy Immunol 50(3):345–356. https://doi.org/10.1007/s12016-016-8538-7CrossRefPubMed

10.

Molina H, Wong W, Kinoshita T, Brenner C, Foley S, Holers VM (1992) Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1. J Exp Med 175(1):121–129CrossRef

11.

Kuhns DB, Hsu AP, Sun D, Lau K, Fink D, Griffith P, Huang DW, Priel DAL, Mendez L, Kreuzburg S, Zerbe CS, De Ravin SS, Malech HL, Holland SM, Wu X, Gallin JI (2019) NCF1 (p47(phox))-deficient chronic granulomatous disease: Comprehensive genetic and flow cytometric analysis. Blood Adv 3(2):136–147. https://doi.org/10.1182/bloodadvances.2018023184CrossRefPubMedPubMedCentral

12.

Cho JH, Gregersen PK (2011) Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med 365(17):1612–1623. https://doi.org/10.1056/NEJMra1100030CrossRefPubMed

13.

Margariti A, Winkler B, Karamariti E, Zampetaki A, Tsai TN, Baban D, Ragoussis J, Huang Y, Han JD, Zeng L, Hu Y, Xu Q (2012) Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels. Proc Natl Acad Sci U S A 109(34):13793–13798. https://doi.org/10.1073/pnas.1205526109CrossRefPubMedPubMedCentral

14.

Reue K, Lee JM, Vergnes L (2014) Regulation of bile acid homeostasis by the intestinal Diet1-FGF15/19 axis. Curr Opin Lipidol 25(2):140–147. https://doi.org/10.1097/MOL.0000000000000060CrossRefPubMedPubMedCentral

15.

Tilley AE, Walters MS, Shaykhiev R, Crystal RG (2015) Cilia dysfunction in lung disease. Annu Rev Physiol 77:379–406. https://doi.org/10.1146/annurev-physiol-021014-071931CrossRefPubMed

16.

Simmler MC, Cohen-Salmon M, El-Amraoui A, Guillaud L, Benichou JC, Petit C, Panthier JJ (2000) Targeted disruption of otog results in deafness and severe imbalance. Nat Genet 24(2):139–143. https://doi.org/10.1038/72793CrossRefPubMed

17.

Kerst B, Mennerich D, Schuelke M, Stoltenburg-Didinger G, von Moers A, Gossrau R, van Landeghem FK, Speer A, Braun T, Hubner C (2000) Heterozygous myogenic factor 6 mutation associated with myopathy and severe course of Becker muscular dystrophy. Neuromuscul Disord 10(8):572–577CrossRef

18.

Roy MG, Livraghi-Butrico A, Fletcher AA, McElwee MM, Evans SE, Boerner RM, Alexander SN, Bellinghausen LK, Song AS, Petrova YM, Tuvim MJ, Adachi R, Romo I, Bordt AS, Bowden MG, Sisson JH, Woodruff PG, Thornton DJ, Rousseau K, De la Garza MM, Moghaddam SJ, Karmouty-Quintana H, Blackburn MR, Drouin SM, Davis CW, Terrell KA, Grubb BR, O’Neal WK, Flores SC, Cota-Gomez A, Lozupone CA, Donnelly JM, Watson AM, Hennessy CE, Keith RC, Yang IV, Barthel L, Henson PM, Janssen WJ, Schwartz DA, Boucher RC, Dickey BF, Evans CM (2014) Muc5b is required for airway defence. Nature 505(7483):412–416. https://doi.org/10.1038/nature12807CrossRefPubMed

19.

Favre B, Begre N, Borradori L (2018) A recessive mutation in the DSP gene linked to cardiomyopathy, skin fragility and hair defects impairs the binding of desmoplakin to epidermal keratins and the muscle-specific intermediate filament desmin. Br J Dermatol 179(3):797–799. https://doi.org/10.1111/bjd.16832CrossRefPubMed

20.

Kuo HH, Ahmad R, Lee GQ, Gao C, Chen HR, Ouyang Z, Szucs MJ, Kim D, Tsibris A, Chun TW, Battivelli E, Verdin E, Rosenberg ES, Carr SA, Yu XG, Lichterfeld M (2018) Anti-apoptotic protein BIRC5 maintains survival of HIV-1-infected CD4(+) T cells. Immunity 48(6):1183–1194 e1185. https://doi.org/10.1016/j.immuni.2018.04.004CrossRefPubMedPubMedCentral

21.

Mason JM, Morrison DJ, Basson MA, Licht JD (2006) Sprouty proteins: Multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. Trends Cell Biol 16(1):45–54. https://doi.org/10.1016/j.tcb.2005.11.004CrossRefPubMed

22.

Haag S, Warda AS, Kretschmer J, Gunnigmann MA, Hobartner C, Bohnsack MT (2015) NSUN6 is a human RNA methyltransferase that catalyzes formation of m5C72 in specific tRNAs. RNA 21(9):1532–1543. https://doi.org/10.1261/rna.051524.115CrossRefPubMedPubMedCentral

23.

Mannik J, Vaas P, Rull K, Teesalu P, Rebane T, Laan M (2010) Differential expression profile of growth hormone/chorionic somatomammotropin genes in placenta of small- and large-for-gestational-age newborns. J Clin Endocrinol Metab 95(5):2433–2442. https://doi.org/10.1210/jc.2010-0023CrossRefPubMedPubMedCentral

24.

Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, Lees CW, Balschun T, Lee J, Roberts R, Anderson CA, Bis JC, Bumpstead S, Ellinghaus D, Festen EM, Georges M, Green T, Haritunians T, Jostins L, Latiano A, Mathew CG, Montgomery GW, Prescott NJ, Raychaudhuri S, Rotter JI, Schumm P, Sharma Y, Simms LA, Taylor KD, Whiteman D, Wijmenga C, Baldassano RN, Barclay M, Bayless TM, Brand S, Buning C, Cohen A, Colombel JF, Cottone M, Stronati L, Denson T, De Vos M, D’Inca R, Dubinsky M, Edwards C, Florin T, Franchimont D, Gearry R, Glas J, Van Gossum A, Guthery SL, Halfvarson J, Verspaget HW, Hugot JP, Karban A, Laukens D, Lawrance I, Lemann M, Levine A, Libioulle C, Louis E, Mowat C, Newman W, Panes J, Phillips A, Proctor DD, Regueiro M, Russell R, Rutgeerts P, Sanderson J, Sans M, Seibold F, Steinhart AH, Stokkers PC, Torkvist L, Kullak-Ublick G, Wilson D, Walters T, Targan SR, Brant SR, Rioux JD, D’Amato M, Weersma RK, Kugathasan S, Griffiths AM, Mansfield JC, Vermeire S, Duerr RH, Silverberg MS, Satsangi J, Schreiber S, Cho JH, Annese V, Hakonarson H, Daly MJ, Parkes M (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet 42(12):1118–1125. https://doi.org/10.1038/ng.717CrossRefPubMedPubMedCentral

25.

Zhao J, Ma J, Deng Y, Kelly JA, Kim K, Bang SY, Lee HS, Li QZ, Wakeland EK, Qiu R, Liu M, Guo J, Li Z, Tan W, Rasmussen A, Lessard CJ, Sivils KL, Hahn BH, Grossman JM, Kamen DL, Gilkeson GS, Bae SC, Gaffney PM, Shen N, Tsao BP (2017) A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases. Nat Genet 49(3):433–437. https://doi.org/10.1038/ng.3782CrossRefPubMedPubMedCentral

26.

Danese S, Argollo M, Le Berre C, Peyrin-Biroulet L (2019) JAK selectivity for inflammatory bowel disease treatment: Does it clinically matter? Gut. https://doi.org/10.1136/gutjnl-2019-318448

27.

Itoh A, Yamaguchi E, Furuya K, Hizawa N, Ohnuma N, Kawakami Y, Kuzumaki N (1993) Correlation of GM-CSF mRNA in bronchoalveolar fluid with indices of clinical activity in sarcoidosis. Thorax 48(12):1230–1234CrossRef

28.

Prior C, Haslam PL (1991) Increased levels of serum interferon-gamma in pulmonary sarcoidosis and relationship with response to corticosteroid therapy. Am Rev Respir Dis 143(1):53–60. https://doi.org/10.1164/ajrccm/143.1.53CrossRefPubMed

29.

Timmermans WM, van Laar JA, van Hagen PM, van Zelm MC (2016) Immunopathogenesis of granulomas in chronic autoinflammatory diseases. Clin Transl Immunol 5(12):e118. https://doi.org/10.1038/cti.2016.75CrossRef

30.

Zhou T, Casanova N, Pouladi N, Wang T, Lussier Y, Knox KS, Garcia JGN (2017) Identification of Jak-STAT signaling involvement in sarcoidosis severity via a novel microRNA-regulated peripheral blood mononuclear cell gene signature. Sci Rep 7(1):4237. https://doi.org/10.1038/s41598-017-04109-6CrossRefPubMedPubMedCentral

31.

Fischer A, Nothnagel M, Franke A, Jacobs G, Saadati HR, Gaede KI, Rosenstiel P, Schurmann M, Muller-Quernheim J, Schreiber S, Hofmann S (2011) Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes. Eur Respir J 37(3):610–616. https://doi.org/10.1183/09031936.00049410CrossRefPubMed

32.

Lee JC, Biasci D, Roberts R, Gearry RB, Mansfield JC, Ahmad T, Prescott NJ, Satsangi J, Wilson DC, Jostins L, Anderson CA, Consortium UIG, Traherne JA, Lyons PA, Parkes M, Smith KG (2017) Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn’s disease. Nat Genet 49(2):262–268. https://doi.org/10.1038/ng.3755CrossRefPubMedPubMedCentral

33.

Tran V, Shammas RM, Sauk JS, Padua D (2019) Evaluating tofacitinib citrate in the treatment of moderate-to-severe active ulcerative colitis: Design development and positioning of therapy. Clin Exp Gastroenterol 12:179–191. https://doi.org/10.2147/CEG.S150908CrossRefPubMedPubMedCentral

34.

Damsky W, Thakral D, Emeagwali N, Galan A, King B (2018) Tofacitinib treatment and molecular analysis of cutaneous sarcoidosis. N Engl J Med 379(26):2540–2546. https://doi.org/10.1056/NEJMoa1805958CrossRefPubMedPubMedCentral

35.

Roychoudhuri R, Hirahara K, Mousavi K, Clever D, Klebanoff CA, Bonelli M, Sciume G, Zare H, Vahedi G, Dema B, Yu Z, Liu H, Takahashi H, Rao M, Muranski P, Crompton JG, Punkosdy G, Bedognetti D, Wang E, Hoffmann V, Rivera J, Marincola FM, Nakamura A, Sartorelli V, Kanno Y, Gattinoni L, Muto A, Igarashi K, O’Shea JJ, Restifo NP (2013) BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis. Nature 498(7455):506–510. https://doi.org/10.1038/nature12199CrossRefPubMedPubMedCentral

36.

De Ravin SS, Naumann N, Robinson MR, Barron KS, Kleiner DE, Ulrick J, Friend J, Anderson VL, Darnell D, Kang EM, Malech HL (2006) Sarcoidosis in chronic granulomatous disease. Pediatrics 117(3):e590–e595. https://doi.org/10.1542/peds.2005-1349CrossRefPubMed

37.

Hultqvist M, Olofsson P, Holmberg J, Backstrom BT, Tordsson J, Holmdahl R (2004) Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci U S A 101(34):12646–12651. https://doi.org/10.1073/pnas.0403831101CrossRefPubMedPubMedCentral

38.

Gardiner GJ, Deffit SN, McLetchie S, Perez L, Walline CC, Blum JS (2013) A role for NADPH oxidase in antigen presentation. Front Immunol 4:295. https://doi.org/10.3389/fimmu.2013.00295CrossRefPubMedPubMedCentral

39.

Werner JL, Escolero SG, Hewlett JT, Mak TN, Williams BP, Eishi Y, Nunez G (2017) Induction of pulmonary granuloma formation by Propionibacterium acnes is regulated by MyD88 and Nox2. Am J Respir Cell Mol Biol 56(1):121–130. https://doi.org/10.1165/rcmb.2016-0035OCCrossRefPubMedPubMedCentral

40.

Chen ES, Moller DR (2015) Etiologies of sarcoidosis. Clin Rev Allergy Immunol 49(1):6–18. https://doi.org/10.1007/s12016-015-8481-zCrossRefPubMed

41.

Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J (1997) HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 156(5):1601–1605. https://doi.org/10.1164/ajrccm.156.5.9704069CrossRefPubMed

42.

Thompson CL, Rybicki BA, Iannuzzi MC, Elston RC, Iyengar SK, Gray-McGuire C, Sarcoidosis Genetic Analysis C (2006) Reduction of sample heterogeneity through use of population substructure: An example from a population of African American families with sarcoidosis. Am J Hum Genet 79(4):606–613. https://doi.org/10.1086/507847CrossRefPubMedPubMedCentral

43.

Schurmann M, Lympany PA, Reichel P, Muller-Myhsok B, Wurm K, Schlaak M, Muller-Quernheim J, du Bois RM, Schwinger E (2000) Familial sarcoidosis is linked to the major histocompatibility complex region. Am J Respir Crit Care Med 162(3 Pt 1):861–864. https://doi.org/10.1164/ajrccm.162.3.9901099CrossRefPubMed

44.

Calender A, Rollat Farnier PA, Buisson A, Pinson S, Bentaher A, Lebecque S, Corvol H, Abou Taam R, Houdouin V, Bardel C, Roy P, Devouassoux G, Cottin V, Seve P, Bernaudin JF, Lim CX, Weichhart T, Valeyre D, Pacheco Y, Clement A, Nathan N, in the frame of GSF (2018) Whole exome sequencing in three families segregating a pediatric case of sarcoidosis. BMC Med Genet 11(1):23. https://doi.org/10.1186/s12920-018-0338-xCrossRef

45.

Calender A, Lim CX, Weichhart T, Buisson A, Besnard V, Rollat-Farnier PA, Bardel C, Roy P, Cottin V, Devouassoux G, Finat A, Pinson S, Lebecque S, Nunes H, Israel-Biet D, Bentaher A, Valeyre D, Pacheco Y, in the frame of GSF (2019) Exome sequencing and pathogenicity-network analysis of five French families implicate mTOR signalling and autophagy in familial sarcoidosis. Eur Respir J 54(2). https://doi.org/10.1183/13993003.00430-2019

46.

Kishore A, Petersen BS, Nutsua M, Muller-Quernheim J, Franke A, Fischer A, Schreiber S, Petrek M (2018) Whole-exome sequencing identifies rare genetic variations in German families with pulmonary sarcoidosis. Hum Genet 137(9):705–716. https://doi.org/10.1007/s00439-018-1915-yCrossRefPubMed

47.

Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, Abecasis GR (2015) A global reference for human genetic variation. Nature 526(7571):68–74. https://doi.org/10.1038/nature15393CrossRef

Title: Whole genome sequencing identifies variants associated with sarcoidosis in a family with a high prevalence of sarcoidosis
Authors: Daan Fritz
Bart Ferwerda
Matthijs C. Brouwer
Diederik van de Beek
Publication date: 01-09-2021
Publisher: Springer International Publishing
Keywords: Sarcoidosis
Sarcoidosis
Published in: Clinical Rheumatology / Issue 9/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-021-05684-w

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2021

The management of gout in Africa: challenges and opportunities

Prevalence of pediatric Kashin-Beck disease in Tibet

A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review

Rheumatology care of migrants from sub-Saharan Africa: a literature review and qualitative pilot study of patients’ perspectives

Cutaneous manifestations are frequent and diverse among patients with rheumatoid arthritis and impact their quality of life: a cross-sectional study in a cohort of patients with recent-onset disease

Editorial—Rheumatology in Africa

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage